← All tickers

Is IRWD Worth Buying in 2026?

Ironwood Pharmaceuticals, Inc. - Class A

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-23

Here’s whether Ironwood Pharmaceuticals, Inc. - Class A (IRWD) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.53% over 10 days); RSI 47 — healthy momentum range; strong 1-year return of +263.6%; 3-month momentum positive (+9.4%). Currently 25.8% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

IRWD is in a confirmed uptrend, trading above both its 50-day ($4.06) and 200-day ($3.85) moving averages. An RSI of 46.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +263.6% compares to +20.5% for SPY (beat the market by 243.1%). The current 25.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $36,356 today
vs. S&P 500 (SPY) — same period beat market by 243.1%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($3.85)
✓Above 50-day MA ($4.06)
✓RSI(14) neutral zone (30–70) — currently 46.7
✓Positive return (+263.6%)
!Within 10% of period high (−25.8%)
Period Range $4.29
$1.01 $5.78
RSI (14) 46.7
0 · OversoldOverbought · 100

Key Metrics

Price$4.29
Period Return+263.6%
Period High$5.78
Period Low$1.01
Drawdown−25.8%
MA-50$4.06
MA-200$3.85
RSI (14)46.7
Avg Volume (30d)2.1M
vs. SPYbeat by 243.1%
Return Rank#41 of 999

Trade IRWD

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers